In BL, knockdown of MCM3AP-AS1 can enhance drug sensitivity, promote cell cycle progression, and promote apoptosis by regulating EIF4E and its downstream anti-apoptotic proteins [39]. This evidence concerns the gene EIF4E and Burkitt lymphoma.